{"pub": "afr", "url": "https://afr.com/street-talk/bankers-scan-buyers-for-affinity-s-medicaldirector-20191020-p532ed", "downloaded_at": "2019-10-20 12:29:40.069753+00:00", "title": "Bankers scan buyers for Affinity's MedicalDirector", "language": "en", "text": "Pan-Asian private equity firm Affinity Equity Partners has been talking to investment bankers about the future of its Australian medical practice software company MedicalDirector as it gets ready to consider exit options.\n\nStreet Talk understands Affinity's operatives have given a handful of bulge bracket investment banks an update in recent weeks to explain what it had done to the business during the past three years and where it was headed.\n\nAffinity Equity Partners bought MedicalDirector for $155 million in 2016. Jim Rice\n\nWhile sources said there were no formal mandates up for grabs \u2013 yet \u2013 Affinity was also keen to test bankers' ideas on potential exit options, sale strategies and even valuation.\n\nThe private equity dealmakers have seen a handful of comparable deals offshore and were keen to know where appetite may come from for MedicalDirector.\n\nIt is understood the meetings have been enough", "description": "Affinity Equity Partners has been talking to investment bankers about the future of MedicalDirector.", "authors": [], "top_image": "https://static.ffx.io/images/$zoom_0.5298%2C$multiply_0.7554%2C$ratio_1.777778%2C$width_1059%2C$x_0%2C$y_110/t_crop_custom/e_sharpen:25%2Cq_85%2Cf_auto/f4082e5e02900e00acdb68f5ba5518779cd38ede", "published_at": "2019-10-20"}